The broad spectrum of cardiotoxicities from immunotherapies

Front Cardiovasc Med. 2023 Sep 15:10:1259620. doi: 10.3389/fcvm.2023.1259620. eCollection 2023.

Martina Iengo^#¹, Ester Topa^#¹, Alessandra Cuomo¹, Giancarlo Marone², Remo Poto^{1

3}, Gilda Varricchi^{1

3

4

5}, Leonardo Cristinziano¹, Maria Rosaria Galdiero^{1

3

4}, Anne Lise Ferrara^{1

5}, Stefania Loffredo^{1

3

4

5}, Luigi Formisano^{6

7}, Teresa Troiani⁸, Valentina Mercurio^{1

7

9}, Carlo Gabriele Tocchetti^{1

4

7

9}

¹ Department of Translational Medical Sciences, Federico II University, Naples, Italy.
² Department of Pharmacy, Moscati Hospital Pharmacy, Aversa, Italy.
³ World Allergy Organization (WAO) Center of Excellence, Naples, Italy.
⁴ Center for Basic and Clinical Immunology Research (CISI), Federico II University, Naples, Italy.
⁵ Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council, Naples, Italy.
⁶ Department of Medicine and Surgery, Federico II University, Naples, Italy.
⁷ Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Federico II University, Naples, Italy.
⁸ Medical Oncology, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
⁹ Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.

^# Contributed equally.

No abstract available

Keywords: cardio-oncology; cardiotoxicity; detection; immunotherapy; management.

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article.